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Background: The development of neurological complications due to varicella zoster virus (VZV) reactivation is
relatively uncommon, particularly in the case of immunocompetent patients. Only a few cases have been described
in the literature, most of which involved adult or elderly patients.
Clinical presentation: Two days after his pediatrician had diagnosed herpes zoster and prescribed oral acyclovir
400 mg three times a day, a 14-year-old boy was admitted to our hospital because of mild fever, severe headache,
slowness, drowsiness and vomiting. A cerebrospinal fluid examination was performed and showed an increased
protein concentration (95 mg/dL), normal glucose level (48 mg/dL; blood glucose level, 76 mg/dL) and lymphocytic
pleocytosis (1,400 lymphocytes/μL), and VZV DNA was detected by means of polymerase chain reaction
(1,250 copies/mL). The results of immunological screening for HIV, lymphocyte subpopulation counts, serum
immunoglobulin and complement (C3 and C4) levels, vaccine responsiveness and lymphocytes stimulation tests
were unremarkable. Acyclovir was administered intravenously at a dose of 10 mg/kg three times a day and
continued for 10 days. The therapy was highly effective and the patient’s clinical condition rapidly improved: fever
disappeared after two days, and all of the signs and symptoms of neurological involvement after four days. The skin
lesions resolved in about one week, and no pain or dysesthesia was ever reported. Given the favourable evolution
of the illness, the child was discharged without further therapy after the 10-day treatment. The findings of a
magnetic resonance examination immediately after the discontinuation of the antiviral therapy were normal, and a
control examination carried out about four weeks later did not find any sign or symptom of disease.
Conclusion: VZV reactivation can also lead to various neurological complications in immunocompetent children.
Prompt therapy with acyclovir and the integrity of the immune system are important in conditioning outcome, but
other currently unknown factors probably also play a role.
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Varicella zoster virus (VZV) is an exclusively human neuro-
trophic alphaherpesvirus [1]. Primary infection causes vari-
cella (chickenpox), after which the virus becomes latent in
ganglionic neurons along the entire neuraxis. With advan-
cing age or immunosuppression, cell-mediated immunity
to VZV declines and virus reactivation causes herpes zoster
(shingles) which can be complicated by central and periph-
eral nervous system involvement [2].
The development of the neurological complications of
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stated.case of immunocompetent patients. Only a few cases have
been described in the literature, most of which involved
adult or elderly patients [3-8]. Although there is no evidence
concerning its efficacy, various antiviral regimens have been
prescribed in such cases [2,9], including the administration
of antiviral drugs not indicated for the pediatric population.
We here describe the case of an immunocompetent
adolescent with herpes zoster and aseptic meningitis due
to VZV reactivation because some of the patient’s clinical
characteristics and the outcome of antiviral treatment
make the case interesting.
Case presentation
A 14-year-old boy was admitted to our hospital because of
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admission, his parents had noticed a maculopapular rash
rapidly evolving into vescicles with an erythematous basis
in a very limited region of the left dorsal skin. No other sign
or symptom was reported. The patient’s pediatrician diag-
nosed herpes zoster and prescribed oral acyclovir 400 mg
three times a day. The boy’s medical history was uneventful
except for recurrent respiratory infections in his first three
years of life. He was diagnosed as having varicella when he
was three years old, but did not receive antiviral therapy.
Upon admission, his body temperature was 37.8°C, vital
signs were unremarkable, and the skin lesions located in a
small part of the area supplied with C8 were considered
consistent with a diagnosis of herpes zoster. At the same
time, a neurological examination revealed typical signs
and symptoms of meningeal involvement: the patient was
slightly confused and unable to tolerate bright light,
his deep tendon reflexes were exaggerated, and he was
positive for Brudzinski’s and Kernig’s signs. However,
there was no sensory deficit. The results of routine blood
examinations were within normal ranges, and there was no
increase in inflammatory biomarkers. The findings of brain
computed tomography (CT) and electroencephalography
examinations were normal. A cerebrospinal fluid (CSF)
examination showed an increased protein concentration
(95 mg/dL), normal glucose level (48 mg/dL; blood glucose
level, 76 mg/dL) and lymphocytic pleocytosis (1,400
lymphocytes/μL). VZV DNA was detected by means of
polymerase chain reaction (PCR, 1,250 copies/mL), whereas
the PCR analyses of herpes simplex virus 1 and 2, entero-
virus, cytomegalovirus, Epstein Barr virus and JC virus were
negative. The results of immunological screening for HIV,
lymphocyte subpopulation counts, serum immunoglobulin
and complement (C3 and C4) levels, vaccine responsiveness
and lymphocytes stimulation tests were unremarkable.
The acyclovir dose was changed to 10 mg/kg three times
a day, which were administered intravenously for 10 days.
The therapy was highly effective and the patient’s clinical
condition rapidly improved: fever disappeared after two
days, and all of the signs and symptoms of neurological
involvement after four days. The skin lesions resolved
in about one week, and no pain or dysesthesia was ever
reported. Given the favourable evolution of the illness,
the child was discharged without further therapy after the
10-day treatment. The findings of a magnetic resonance
examination immediately after the discontinuation of the
antiviral therapy were normal, and a control examination
carried out about four weeks later did not find any sign or
symptom of disease Table 1.
Conclusions
Herpes zoster mainly affects elderly (its incidence is 8–10
times higher in people aged >60 years than in younger
subjects) and immunocompromised patients, includingthose with acquired immunodeficiency due to drug ad-
ministration [10], although bone marrow transplant recip-
ients and HIV-seropositive patients are also at particular
risk [11]. Waning cell-mediated immunity is thought to be
a major factor in the increased incidence of herpes zoster
because antibody titres remain unchanged or may even in-
crease with age [2,11], which explains why there are only a
few reported cases in immunocompetent children [1,3].
After varicella, VZV remains latent in the sensory dorsal
root ganglia and, when reactivated, replicates along the
course of the nerve and appears as a vesicular skin rash
[1,2,9]. In most cases, this is preceded by paresthesia,
itching and pain or “pre-herpetic neuralgia” [2,9], and these
sensory symptoms can be severe enough to suggest an al-
ternative cause, such as coronary ischemia or an abdominal
condition. Pain and itching are the usual concomitants of
the eruption, but they can also follow the rash and become
chronic but self-limiting “post-herpetic neuralgia” [2,9].
Some atypical cases may lead to pain without any skin
lesions, although a significant rise in VZV antibody titres
suggests that the pain is closely related to VZV [2,9,10].
The situation in our patient was the opposite: although
limited in extent, the skin lesions were clear and easily
diagnosed as VZV-related alterations but, surprisingly,
they were not associated with any significant pain or
dysesthesia throughout the duration of the acute disease
or later, including post-herpetic neuralgia. The child had no
sensory neurological deficits that could explain the lack of
pain in a disease that selectively damages sensory nerves.
Consequently, it is reasonable to think that the benign
clinical picture was related to the efficiency of his immune
system despite the fact that VZV involved the central ner-
vous system while he was receiving antiviral therapy. The
positive evolution of the case could also have been due to
the prompt acyclovir treatment, whivh is known to be very
effective against VZV.
Aseptic meningitis is one of the possible complications
of VZV reactivation. It is not one of the most severe
neurological complications and usually does not lead to
the major brain damage characterising VZV myelopathy,
vasculopathy or eye disease [2]. In our case, although the
neurological involvement was clinically evident, it was very
mild and did not cause any persistent damage, possibly
because oral antiviral therapy was started as soon as
herpes zoster was diagnosed and, even if it could not
have led to high acyclovir concentrations in the CSF, it
may have attenuated the severity of the meningitis and
favoured a positive clinical outcome. In this regard, this
case resembles those recently described by Mantero et al.
[4] and Goyal et al. [5], who respectively described VZV
meningoencephaloradiculoneuropathy in an immunocom-
petent young woman with meningitis and cranial palsy and
meningitis in a 27-year-old man, both of whom completely
recovered. However, these patients received prolonged






Age at time of developing varicella 3 years
Clinical problems Recurrent respiratory tract infections in the first three years of life
Clinical presentation upon admission
Axillary temperature 37.8°C
Skin lesions Dorsal herpes zoster (C8)
Neurological symptoms and signs Headache, slowness, drowsiness, unable to tolerate bright light, vomiting, stiff neck,
exaggerated deep tendon reflexes, positive Brudzinski’s and Kernig’s signs
Diagnostic examinations upon admission
White blood count 7,280/μL
Lymphocytes 31.7%
C-reactive protein 0.10 mg/dL
CSF examination Protein 95 mg/dL, glucose 48 mg/dL, 1,400 lymphocytes/μL, PCR positive for VZV DNA
1,250 cp/mL, PCR negative for herpes simplex virus 1 and 2, enterovirus, cytomegalovirus,
Epstein Barr virus, JC virus
Immunological screening HIV negative, normal lymphocyte subpopulation counts, normal serum immunoglobulin
and complement levels, vaccine responsiveness and lymphocytes stimulation tests
Electroencephalography Normal
CT and MR Normal
Antiviral therapy
Oral acyclovir 400 mg 3 times a day for 48 hours (administered at home before neurological involvement)
Intravenous acyclovir 10 mg/kg 3 times a day for 10 days (administered after admission because of meningitis)
Outcome
Duration of fever 2 days
Duration of neurological involvement 4 days
Duration of vescicular eruption 7 days
Duration of hospitalisation 10 days
Clinical evaluation after one month Normal with absence of neurological involvement
CSF: cerebrospinal fluid; CT: computed tomography; MR: magnetic resonance; PCR: polymerase chain reaction; VZV: varicella zoster virus.
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10 days of intravenous treatment. Further information
should be collected concerning when and how long
antiviral treatment should be administered to patients with
neurological involvement due to VZV reactivation.
The findings of the immunological examinations of
our child were normal, but a normal immune system
does not guarantee the benign course of the neurological
manifestations of VZV reactivation. Mpaka et al. have
described the case of a previously healthy 66-year-old
man whose obtundation deteriorated to coma within
24 hours of disease onset [6] after the development of
lymphocytic meningitis with multiple, bilateral edema-
tous and hemorrhagic lesions predominantly in the
white matter, and intraventricular and subarachnoidhemorrhaging. The diagnosis of VZV encephalitis was
confirmed by PCR analysis of the CSF, and he received
adequate treatment with acyclovir. However, although
his general condition was considered good two years
later, this case shows that meningitis induced by VZV
reactivation can have a complicated evolution even in
immunocompetent subjects.
Our case underlines the fact that VZV reactivation can
also lead to various neurological complications in immuno-
competent children, which may be benign (as in our case)
or very severe [2,10]. Prompt therapy with acyclovir and
the integrity of the immune system are important in con-
ditioning outcome, but other currently unknown factors
probably also play a role. Further studies are needed to
clarify the relationships between VZV and neural damage.
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